Stratec Biomedical Ag Stock Market Value

SRBZF Stock  USD 72.96  0.00  0.00%   
STRATEC Biomedical's market value is the price at which a share of STRATEC Biomedical trades on a public exchange. It measures the collective expectations of STRATEC Biomedical AG investors about its performance. STRATEC Biomedical is trading at 72.96 as of the 2nd of January 2026. This is a No Change since the beginning of the trading day. The stock's lowest day price was 72.96.
With this module, you can estimate the performance of a buy and hold strategy of STRATEC Biomedical AG and determine expected loss or profit from investing in STRATEC Biomedical over a given investment horizon. Check out STRATEC Biomedical Correlation, STRATEC Biomedical Volatility and STRATEC Biomedical Alpha and Beta module to complement your research on STRATEC Biomedical.
Symbol

Please note, there is a significant difference between STRATEC Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATEC Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATEC Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

STRATEC Biomedical 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to STRATEC Biomedical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of STRATEC Biomedical.
0.00
10/04/2025
No Change 0.00  0.0 
In 2 months and 31 days
01/02/2026
0.00
If you would invest  0.00  in STRATEC Biomedical on October 4, 2025 and sell it all today you would earn a total of 0.00 from holding STRATEC Biomedical AG or generate 0.0% return on investment in STRATEC Biomedical over 90 days. STRATEC Biomedical is related to or competes with NVIDIA, Apple, Alphabet, Microsoft, Amazon, Bristol Myers, and Meta Platforms. More

STRATEC Biomedical Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure STRATEC Biomedical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess STRATEC Biomedical AG upside and downside potential and time the market with a certain degree of confidence.

STRATEC Biomedical Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for STRATEC Biomedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as STRATEC Biomedical's standard deviation. In reality, there are many statistical measures that can use STRATEC Biomedical historical prices to predict the future STRATEC Biomedical's volatility.
Hype
Prediction
LowEstimatedHigh
72.9672.9672.96
Details
Intrinsic
Valuation
LowRealHigh
72.9672.9672.96
Details
Naive
Forecast
LowNextHigh
72.9672.9672.96
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
72.9672.9672.96
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as STRATEC Biomedical. Your research has to be compared to or analyzed against STRATEC Biomedical's peers to derive any actionable benefits. When done correctly, STRATEC Biomedical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in STRATEC Biomedical.

STRATEC Biomedical Backtested Returns

We have found three technical indicators for STRATEC Biomedical AG, which you can use to evaluate the volatility of the company. The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and STRATEC Biomedical are completely uncorrelated.

Auto-correlation

    
  0.00  

No correlation between past and present

STRATEC Biomedical AG has no correlation between past and present. Overlapping area represents the amount of predictability between STRATEC Biomedical time series from 4th of October 2025 to 18th of November 2025 and 18th of November 2025 to 2nd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of STRATEC Biomedical price movement. The serial correlation of 0.0 indicates that just 0.0% of current STRATEC Biomedical price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test1.0
Residual Average0.0
Price Variance0.0

STRATEC Biomedical lagged returns against current returns

Autocorrelation, which is STRATEC Biomedical pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting STRATEC Biomedical's pink sheet expected returns. We can calculate the autocorrelation of STRATEC Biomedical returns to help us make a trade decision. For example, suppose you find that STRATEC Biomedical has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

STRATEC Biomedical regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If STRATEC Biomedical pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if STRATEC Biomedical pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in STRATEC Biomedical pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

STRATEC Biomedical Lagged Returns

When evaluating STRATEC Biomedical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of STRATEC Biomedical pink sheet have on its future price. STRATEC Biomedical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, STRATEC Biomedical autocorrelation shows the relationship between STRATEC Biomedical pink sheet current value and its past values and can show if there is a momentum factor associated with investing in STRATEC Biomedical AG.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in STRATEC Pink Sheet

STRATEC Biomedical financial ratios help investors to determine whether STRATEC Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in STRATEC with respect to the benefits of owning STRATEC Biomedical security.